Prevention Training for HIV Risk Reduction (SISTA-P Trial)

N/A

Recruiting

Led By Shawnika Hull, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the end of each cycle (each cycle is 42 days)

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to provide specialized HIV prevention training and empowerment sessions to Black women in Washington D.C. who are at high risk for contracting HIV. The goal is to lower the rates of HIV transmission within

Who is the study for?

This trial is specifically for Black women aged 18 or older who are sexually active with men, live in Washington D.C., and do not have HIV. It aims to empower them with HIV prevention training tailored to their experiences.

What is being tested?

The SISTA-P Intervention is being tested, which involves new HIV prevention training and empowerment sessions designed for the unique challenges faced by Black women in reducing HIV transmission rates within their community.

What are the potential side effects?

Since this intervention focuses on education and empowerment without medical treatments, there are no direct physical side effects. However, participants may experience emotional or psychological impacts from discussing sensitive topics.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the end of each cycle (each cycle is 42 days)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the end of each cycle (each cycle is 42 days)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of each cycle (each cycle is 42 days) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the Intervention Scale

Appropriateness of the Intervention Scale

Feasibility of the Intervention Scale

Secondary study objectives

Acceptability of the intervention delivery

Feasibility of delivering 6 sessions in 6 weeks

Intervention Fidelity

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: SISTA-P InterventionExperimental Treatment1 Intervention

Participants will complete four sessions lasting up to three hours each over the course of one week. The sessions will be overseen by two facilitators and a technical monitor. Core elements of SISTA-P are: (1) small group discussions, modeling and role-play that facilitate repetition, reinforcement and sequential approximation; (2) skilled facilitators; (3) gender and culturally specific materials to enhance pride and self-worth; (4) teaching negotiation, self-advocacy; and (5) HIV prevention relevant skills; (6) discussing gender and culture-specific barriers and facilitators to prevention; and (7) enhancing HIV prevention norms and self-efficacy. Each discussion group will consist of 12- 15 participants and each cycle will consist of one group. Participants will be asked to complete a follow up survey and two booster sessions. They will also be asked to submit photo-confirmation of PrEP prescription to the research team.

Do I qualify?Apply below to find out